Antisense Therapeutics reports preliminary phase II data on ATL-1102 in Duchenne muscular dystrophy Sep. 18, 2019
Saniona reports phase IIa data analysis on Tesomet in adolescents with Prader-Willi syndrome Sep. 18, 2019
Novel oxyntomodulin analogue OXM-001 reduces body weight and improves glucose tolerance Sep. 18, 2019
RSS